P3 Health Partners (PIII) Cost of Revenue (2021 - 2025)

P3 Health Partners (PIII) has reported Cost of Revenue for 5 consecutive years, with $335000.0 the latest figure, recorded in Q4 2025.

• Cost of Revenue for Q4 2025 came in at $335000.0, down 99.98% year-over-year; the trailing twelve-month figure through Dec 2025 was $724.0 million (down 62.37% YoY), and the FY2025 annual result was $918000.0, down 99.94% from the prior year.
• Cost of Revenue was $335000.0 for Q4 2025 at P3 Health Partners, up from $251000.0 in the prior quarter.
• Over five years, Cost of Revenue peaked at $1.6 billion in Q4 2024 and troughed at -$346.4 million in Q4 2021.
• Average Cost of Revenue over 5 years is $256.2 million, with a median of $208.1 million recorded in 2021.
• The widest YoY moves for Cost of Revenue: up 115441.3% in 2025, down 99.98% in 2025.
• Over 5 years, Cost of Revenue stood at -$346.4 million in 2021, then surged by 404.19% to $1.1 billion in 2022, then tumbled by 65.11% to $367.7 million in 2023, then surged by 323.88% to $1.6 billion in 2024, then slumped by 99.98% to $335000.0 in 2025.
• Per Business Quant data, the three most recent Cost of Revenue figures were $335000.0 in Q4 2025, $251000.0 in Q3 2025, and $351.3 million in Q2 2025.